Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomePfizer Inc.

      Pfizer Inc.

      Pfizer Stock up as It Enters Deal With Zentalis to Study Phase 1/2 ZN-c3 Trial for Colorectal Cancer  
      Investing News

      Pfizer Stock up as It Enters Deal With Zentalis to Study Phase 1/2 ZN-c3 Trial for Colorectal Cancer  

      October 24, 2022
      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID
      Investing News

      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID

      September 22, 2022
      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs
      Investing News

      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs

      August 24, 2022
      Is Pfizer Stock a Ticking Time Bomb?
      Investing News

      Is Pfizer Stock a Ticking Time Bomb?

      August 4, 2022
      « 1 2 3

       

      LATEST NEWS

      • Investing News Disney’s Q3 2026 Earnings Overview
      • Investing News CVS Health Q2 2026 Earnings Overview
      • Investing News Eli Lilly Q2 2026 Earnings Surge
      • Investing News Uber’s Q2 2026 Earnings Overview
      • Investing News Disney’s Streaming Strategy Evolves

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026